Terns Pharmaceuticals, Inc. offers two differentiated late-stage assets—TERN-701 for CML and TERN-601 for obesity—with major data catalysts expected in Q4 2025. TERN-701 shows early signs of best-in-class potential in CML, with encouraging molecular response and safety data versus Novartis' Scemblix. TERN-601's oral GLP-1 candidate demonstrated promising weight loss and tolerability, targeting a massive obesity market with room for differentiated entrants.

JLL stock gains momentum as outsourcing trends, business resilience and strategic growth boost investor confidence.

Silver prices surged to a nearly 14-year high on Friday as mounting geopolitical tensions and renewed safe-haven demand lifted the precious metal, offsetting pressure from a stronger dollar and mixed trading volumes. Spot silver (XAG/USD) climbed 1.31% to $37.52 per troy ounce, its highest level since 2011, according to FXStreet data.

T-Mobile told the FCC this week that it was ending its DEI policies. The company has been awaiting FCC approval for two deals.

TKO Group's UFC-WWE combo drives robust financials, with double-digit EPS growth, high free cash flow conversion, and expanding margins fueling long-term upside. Despite a premium valuation, my fair value model shows TKO trades at a discount, supported by conservative growth assumptions and strong operational execution. Risks include integration challenges, media rights negotiations, macro headwinds, and live event unpredictability, but TKO's resilient model mitigates these concerns.

The iShares TIPS Bond ETF is set to face an interesting period amid a recalibration in real and nominal yields. The ETF, which has an expense ratio of 0.18% and a 30-day SEC yield of 5.14%, invests in inflation-linked treasuries. We anticipate real yields to settle lower in the next six months. However, we think inflation and breakevens will fall in tandem, softening TIP ETF's return outlook.

Markel Group is set to grow on rate increases, strategic buyouts, new business volume, solid capital position and prudent capital deployment.

CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.

Ford recalls over 850K vehicles in its 89th action this year, citing fuel pump issues that may cause engine stalls.

HOOD's crypto push and rapid growth clash with SCHW's scale and stability? Let's find out which brokerage stock may lead the next wave of finance.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025. Iovance is a commercial stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Iovance Biothera.

Capricor Therapeutics (NASDAQ:CAPR) shares plummeted more than 26% after it reported the US Food and Drug Administration (FDA) has not approved its Biologics License Application for deramiocel, the company's lead cell therapy candidate for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD). In a Complete Response Letter to Capricor, the FDA stated that the application did not meet the statutory requirement for substantial evidence of effectiveness and requested additional clinical data before reconsidering approval.

VCTR's AUM rose 3.2% in June, driven by strong gains across equity, solutions, and fixed-income categories.

Assurant rides on growth in capital-light businesses, Connected Living, and Global Housing, supported by solid cash flow and strategic capital deployment.

UK banks have had their fair share of in-flight turbulence, but analysts still see them heading for a stable landing. According to UBS, domestic lenders have largely closed the gap with their European peers in terms of valuation, and the outlook remains constructive despite some short-term headwinds.

Wells Fargo gains flexibility, but can it edge past JPMorgan's scale and IB dominance? Let's explore how capital returns, growth plans and valuations stack up.

Cadence Design Systems CDNS stock has rallied 23.8% over the past three months. The stock closed last trading session at $322.66 and is now closer to its 52-week high of $330.09.

Palo Alto Networks' FCF margin rose to 25.3% in Q3 as AI platforms drive scale and multi-product deals build long-term momentum.

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to six classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2025-8 (AOMT 2025-8), a $271.3 million non-prime RMBS transaction. The underlying collateral, comprised of 550 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. All the loans are either classified as non-qualified mortgages (46.3%) or exempt (53.7%) from the Ability-to-Repay/Qua.